MICONAZOLE Drug Patent Profile
✉ Email this page to a colleague
When do Miconazole patents expire, and what generic alternatives are available?
Miconazole is a drug marketed by Taro, Perrigo, P And L, Cosette, Perrigo R And D, Teva, Teva Pharms, Actavis Pharma, and L Perrigo Co. and is included in sixteen NDAs.
The generic ingredient in MICONAZOLE is miconazole nitrate. There are twenty-eight drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the miconazole nitrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Miconazole
A generic version of MICONAZOLE was approved as miconazole nitrate by ACTAVIS PHARMA on November 19th, 1993.
Summary for MICONAZOLE
US Patents: | 0 |
Applicants: | 9 |
NDAs: | 16 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MICONAZOLE |
DailyMed Link: | MICONAZOLE at DailyMed |
Recent Clinical Trials for MICONAZOLE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hill Dermaceuticals, Inc. | Phase 3 |
Aesculape CRO Belgium BV | Phase 2 |
Hill Dermaceuticals, Inc. | Phase 2/Phase 3 |